Health and Fitness Health and Fitness
Tue, May 31, 2011
[ 09:08 AM ] - Market Wire
Emergent BioSolutions on Track to Complete Delive .. f BioThrax to the US Government Ahead of Schedule
[ 08:10 AM ] - Market Wire
Healthways to Present at the William Blair & Companya?s 31st Annual Growth Stock Conference
[ 08:00 AM ] - Market Wire
HealthSpring, Inc. to Present at the Jefferies 2011 Global Healthcare Conference
[ 07:00 AM ] - Market Wire
Alexion to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
[ 06:27 AM ] - Market Wire
Healthways Announces Election of Chairman of the Board, John Ballantine
[ 05:30 AM ] - Market Wire
InSite Vision Launches www.AzaSitePlus.com
[ 05:30 AM ] - Market Wire
Cerus to Present at the Jefferies 2011 Global Healthcare Conference
[ 05:15 AM ] - Market Wire
Flamel Technologies propose les candidatures son .. atherine Br©chignac, Guillaume Cerutti et de la?
[ 05:15 AM ] - Market Wire
Flamel Technologies Announces Nomination of Ambas .. therine Br©chignac and Mr. Guillaume Cerutti for
[ 05:10 AM ] - Market Wire
AVEO Pharmaceuticals Enters into Worldwide Licens .. ho Biotech to Develop and Commercialize RON-Targe
[ 05:00 AM ] - Market Wire
Teva Announces Data on Granulocyte Colony Stimula .. Prevention of Chemotherapy-Induced Neutropenia i
[ 05:00 AM ] - Market Wire
Merck to Present at Sanford Bernstein 27th Strategic Decisions Conference
[ 04:55 AM ] - Market Wire
BioSante Pharmaceuticals Completes Enrollment in LibiGel® Phase III Safety Study
[ 04:20 AM ] - Market Wire
Stockholders Approve All Proposals at Galectin Therapeuticsa? Annual Stockholders Meeting
[ 04:00 AM ] - Market Wire
Dyax and Sigma-Tau Group Expand Agreement for KALBITOR® (ecallantide) in Hereditary Angioedema
[ 04:00 AM ] - Market Wire
Spectranetics Introduces First Advanced System fo .. lation of Peripheral Vascular Arterial Occlusions
[ 04:00 AM ] - Market Wire
YM BioSciences Announces Orphan Drug Designation for JAK1/JAK2 Inhibitor CYT387 in Europe
[ 03:30 AM ] - Market Wire
ENZON Names Ana I. Stancic Chief Financial Officer
[ 03:05 AM ] - Market Wire
ZIOPHARM to Present at the Jefferies 2011 Global Healthcare Conference
[ 02:00 AM ] - Market Wire
Affymax and Takeda Announce the Submission of a N .. esatide for the Treatment of Anemia Associated wi
Mon, May 30, 2011
[ 03:00 PM ] - Market Wire
MEDWELL CAPITAL REPORTS FIRST QUARTER 2011 RESULTS
[ 04:00 AM ] - Market Wire
Salix Pharmaceuticals to Present at Three Investment Conferences in June
Fri, May 27, 2011
[ 01:00 PM ] - Market Wire
Curis to Present at the Jefferies 2011 Global Healthcare Conference
[ 07:06 AM ] - Market Wire
Universal American Corp. to Present at the Jeffer .. Global Healthcare Conference on Monday, June 6th
[ 06:00 AM ] - Market Wire
Millennium and Seattle Genetics Announce Brentuxi .. tions at 16th Congress of the European Hematology
[ 05:30 AM ] - Market Wire
InSite Vision to Webcast Annual Meeting of Stockholders on June 1, 2011
[ 05:00 AM ] - Market Wire
Roche Signs Exclusive Agreement with IT-IS Life S .. cler® Nano Instrument for Low-Throughput qPCR Ma
[ 04:30 AM ] - Market Wire
BURCON TO PRESENT AT 13th INTERNATIONAL RAPESEED CONGRESS
[ 03:30 AM ] - Market Wire
AVEO Pharmaceuticals, Inc. to Present at the Jefferies 2011 Global Healthcare Conference
Thu, May 26, 2011
[ 09:45 PM ] - Market Wire
Northwest Biotherapeutics ampla ms su ensayo actual sobre el cncer cerebral

Northwest Biotherapeutics ampla ms su ensayo actual sobre el cncer cerebral


Published on 2011-05-26 22:20:46 - Market Wire
  Print publication without navigation


BETHESDA, Md.--([ BUSINESS WIRE ])--Northwest Biotherapeutics (OTCBB:NWBO) ha anunciado que ha acelerado la incorporacin de los sitios para los ensayos clnicos, superando sus previsiones para duplicar dichos sitios en Estados Unidos este trimestre, para la inscripcin de nuevos pacientes en el ensayo clnico controlado por placebo, doble ciego, aleatorio de 240 pacientes de la empresa de la inmunoterapia DCVax® para glioblastoma multiforme (GBM), la forma ms letal de cncer cerebral.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.

Contributing Sources